Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

With current treatments and vaccines for H5N1 considered insufficient or poorly matched to circulating strains, Arcturus' sa-mRNA approach could offer a more effective solution. However ...

The ongoing Phase 1 study, fully funded by BARDA, aims to evaluate the safety and immune responses of the vaccine, reducing financial strain on Arcturus’ other therapeutic programs. Additionally ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

A 'zombie star' could be resurrected on Halloween night, experts say. T Coronae Borealis, also known as the 'Blaze Star,' is expected to explode, which will illuminate a dead binary star system.

Resolution of the induced stresses and strains in the basement membrane during the merger ... 19 Briefly, DNA was extracted from the isolated crypt stalk and arms using the Arcturus Picopure DNA ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public skepticism (35% comfortable with technology) and challenges translating ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...

A new strain of norovirus now makes up a majority of outbreaks nationwide, according to data from the Centers for Disease Control and Prevention. The new strain's emergence, found spreading ...

Korin Miller is a writer specializing in general wellness, sexual health and relationships, shopping, and lifestyle trends, with work appearing in Women’s Health, Self, Prevention, Daily Beast ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...